TP53 and prostate carcinoma: Our data indicate that p53-induced AIP4 promoted CXCR4 ubiquitination to reduce its protein level and consequently blocked the metastasis of prostate cancer cells to the bone, suggesting AIP4 is a tumor suppressor in prostate cancer.